International Clinical Trial: A Prospective, Single-Arm, Single-Center Phase II Clinical Trial of Iparomlimab/Tuvonralimab as Neoadjuvant Immunotherapy for Locally Advanced Gastric Adenocarcinoma with Microsatellite Instability-High/Deficient Mismatch Repair (MSI-H/dMMR)

Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125006) titled 'A Prospective, Single-Arm, Single-Center Phase II Clinical Trial of Iparomlimab/Tuvonralimab as Neoadjuvant Immunotherapy for Locally Advanced Gastric Adenocarcinoma with Microsatellite Instability-High/Deficient Mismatch Repair (MSI-H/dMMR)' on May 20.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Beijing Cancer Hospital

Condition: Locally Advanced Gastric Adenocarcinoma with Microsatellite Instability-High/Deficient Mismatch Repair (MSI-H/dMMR)

Recruitment Status: Not Recruiting

Phase: 2

Date of First Enrollment: 2026-05-20

Target Sample Size: Experimental Group:30;

Cou...